Metal Sky Star Acquisition Corporation - Right Stock (NASDAQ: MSSAR)

Dernières nouvelles pour Metal Sky Star Acquisition Corporation - Right (NASDAQ:MSSAR) Stock

Metal Sky Star Acquisition Corporation - Right

Willdan Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLDN#NASDAQ">WLDN</a>) raises FY2024 Adj EPS guidance from $2.00-2.10 to $2.15-2.25 vs $2.10 analyst estimate. Raises FY2024 sales outlook from $280.00 million-290.00 million to $285.00 million-295.00 million vs $290.05 million estimate.

News

Guidance

WLDN

Willdan Group Raises FY2024 Adj EPS Guidance from $2.00-2.10 to $2.15-2.25 vs $2.10 Est; Raises FY2024 Sales Guidance from $280.00M-290.00M to $285.00M-295.00M vs $290.05M Est

Camden Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPT#NYSE">CPT</a>) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.37 by 10.81 percent. The company reported quarterly sales of $387.20 million which missed the analyst consensus estimate of $389.39 million by 0.56 percent. This is a 0.92 percent decrease over sales of $390.78 million the same period last year.

Earnings

Earnings Misses

Camden Prop Trust Q3 2024 Adj EPS $0.33 Misses $0.37 Estimate, Sales $387.20M Miss $389.39M Estimate

Codexis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>) affirms FY2024 sales outlook from $56.00 million-64.00 million to $56.00 million-64.00 million.

CDXS

Codexis Affirms FY2024 Product revenues $38M-$42M, R&D revenues $18M-$22M.

United States Steel Corp Says Continue To Work Towards Closing Transaction With Nippon Steel By Year-End

Biotech

General

Bristol Myers Squibb Announced Topline Data From Its Phase 3 Study Of COBENFY That Showed Continuing Improvement In Symptoms Of Schizophrenia

Buybacks

Alamo Group Plans To Repurchase In Aggregate Up To $50M Of Its Outstanding Common Stock

Q4 2024 Outlook
We expect fourth quarter adjusted EBITDA in the range of $225 million and $275 million. Our North American Flat-Rolled segment results should decrease slightly, driven largely by lower lagging average selling price expectations for the quarter. We expect an improvement in Mini Mill segment results, even after accounting for $25 million of related start-up and one-time construction costs at BR2, reflecting an expected improvement in average selling prices. In Europe, results are expected to be lower given the absence of the positive CO2 allocations and weak underlying demand and pricing conditions. Our Tubular segment results should be largely consistent with the third quarter.

U.S. Steel Sees Q4 Adjusted EBITDA In The Range Of $225M-$275M

WIIM

AMCR

Amcor shares are trading lower after the company reported worse-than-expected Q1 financial results.

Sabra Health Care REIT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBRA#NASDAQ">SBRA</a>) raises FY2024 FFO guidance from $1.36-1.39 to $1.39-1.40 vs $1.38 analyst estimate..

SBRA

Sabra Health Care REIT Raises FY2024 FFO Guidance from $1.36-1.39 to $1.39-1.40 vs $1.38 Est

United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.47 by 19.15 percent. This is a 60 percent decrease over earnings of $1.40 per share from the same period last year. The company reported quarterly sales of $3.85 billion which beat the analyst consensus estimate of $3.77 billion by 2.20 percent. This is a 13.04 percent decrease over sales of $4.43 billion the same period last year.

Earnings Beats

United States Steel Q3 Adj $0.56 Beats $0.47 Estimate, Sales $3.85B Beat $3.77B Estimate

VICI Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICI#NYSE">VICI</a>) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.67 by 4.48 percent. The company reported quarterly sales of $964.70 million which beat the analyst consensus estimate of $952.86 million by 1.24 percent. This is a 6.68 percent increase over sales of $904.32 million the same period last year.

VICI

VICI Props Q3 2024 GAAP EPS $0.70 Beats $0.67 Estimate, Sales $964.70M Beat $952.86M Estimate

VIAV

Viavi Solutions Sees Q2 Adj. EPS $0.09-$0.11 Vs $0.08 Est.; Revenue $255M-$265M Vs $248.60M Est.

Willdan Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLDN#NASDAQ">WLDN</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.55 by 32.73 percent. This is a 97.3 percent increase over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $75.69 million which beat the analyst consensus estimate of $72.60 million by 4.25 percent. This is a 15.94 percent increase over sales of $65.28 million the same period last year.

Willdan Group Q3 Adj $0.73 Beats $0.55 Estimate, Sales $75.69M Beat $72.60M Estimate

Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) reported quarterly losses of $(0.64) per share. This is a 28.89 percent increase over losses of $(0.90) per share from the same period last year. The company reported $4.28 million in sales this quarter. This is a 3.52 percent decrease over sales of $4.44 million the same period last year.

MRIN

Marin Software Q3 Adj $(0.64) Up From $(0.90) YoY, Sales $4.28M Down From $4.44M YoY

Wells Fargo analyst Edward Kelly maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Overweight and raises the price target from $88 to $90.

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Walmart, Raises Price Target to $90

License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS Markets Agreement expected to boost NeuroOne sales revenue and profitability
EDEN PRAIRIE, Minn., Oct. 31, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMTC#NASDAQ">NMTC</a>) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the execution of an amendment to its existing distribution agreement with Zimmer Biomet that will provide Zimmer Biomet with certain exclusive rights to distribute NeuroOne's OneRF&#x2122; Ablation System for use in the brain.

NMTC

NeuroOne Announces Expansion Of Existing Distribution Agreement With Zimmer Biomet For Commercialization Of OneRF Ablation System; NeuroOne Will Receive An Upfront Payment Of $3M; License Provides Exclusive Commercialization Rights For U.S. Distribution And Certain OUS Markets

Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) reported quarterly earnings of $6.13 per share which beat the analyst consensus estimate of $5.31 by 15.44 percent. The company reported quarterly sales of $5.651 billion which beat the analyst consensus estimate of $5.126 billion by 10.24 percent. This is a 9.66 percent increase over sales of $5.153 billion the same period last year.

Reinsurance Gr Q3 2024 Adj. EPS $6.13 Beats $5.31 Estimate, Sales $5.651B Beat $5.126B Estimate

TEAM

Atlassian shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 revenue guidance above estimates.

JNPR

Juniper Networks Says Maintains Strong Momentum Entering December Quarter And Remain Optimistic Regarding Long-Term Financial Prospects

Viavi Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. The company reported quarterly sales of $238.200 million which missed the analyst consensus estimate of $240.100 million by 0.79 percent. This is a 3.91 percent decrease over sales of $247.900 million the same period last year.

Comments

Metal Sky Star Acquisition Corporation - Right

Actualités

Dernières nouvelles pour Metal Sky Star Acquisition Corporation - Right (NASDAQ:MSSAR) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL